{{Rsnum
|rsid=2234978
|Gene=FAS
|Chromosome=10
|position=90771829
|Orientation=plus
|GMAF=0.236
|Assembly=GRCh37
|GenomeBuild=37.1
|dbSNPBuild=131
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}
{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 39.3 | 53.6 | 7.1
| HCB | 94.7 | 5.3 | 0.0
| JPT | 92.9 | 7.1 | 0.0
| YRI | 40.0 | 49.0 | 11.0
| ASW | 43.6 | 52.7 | 3.6
| CHB | 94.7 | 5.3 | 0.0
| CHD | 93.5 | 6.5 | 0.0
| GIH | 63.6 | 31.3 | 5.1
| LWK | 39.4 | 44.0 | 16.5
| MEX | 72.7 | 27.3 | 0.0
| MKK | 39.1 | 47.4 | 13.5
| TSI | 46.5 | 43.6 | 9.9
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=20694011
|Trait=None
|Title=Association of IFIH1 and other autoimmunity risk alleles with selective IgA deficiency
|RiskAllele=A
|Pval=0.000006
|OR=1.32
|ORtxt=[1.16-1.50]
}}

{{PMID Auto
|PMID=19669200
|Title=Analysis of single nucleotide polymorphisms in the FAS and CTLA-4 genes of peripheral T-cell lymphomas.
|OA=1
}}

{{PMID Auto
|PMID=20813889
|Title=Genetic variation in the FAS gene and associations with acute lung injury.
|OA=1
}}

{{PMID Auto
|PMID=20959405
|Title=The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.
}}

{{PMID Auto
|PMID=23378343
|Title=MicroRNA-Related Genetic Variants Associated with Clinical Outcomes in Early Stage Non-Small Cell Lung Cancer Patients
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}